Ratings Summary for BUSPAR
Overall Patient opinion of BUSPAR: 2.9 (somewhat satisfied)
(based on 969 reviews ) (updated May 6, 2025)Ratings by Age Group for BUSPAR
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Age Group | Number of Reviews | Average Rating |
|---|---|---|
| Pediatric (Under 18) | 15 | 3.0 |
| Age 18 to 24 | 112 | 2.4 |
| Age 25 to 34 | 276 | 2.4 |
| Age 35 to 44 | 267 | 3.0 |
| Age 45 to 54 | 143 | 3.2 |
| Age 55 to 64 | 100 | 2.7 |
| Age 65 to 74 | 23 | 1.9 |
| Age 75 and up | 2 | 3 |
Ratings by Sex for BUSPAR
Rating Scale from 1 (poor) to 5 (excellent)
| Patient Sex | Number of Reviews | Average Rating |
|---|---|---|
| Male | 326 | 2.92944785276074 |
| Female | 616 | 2.91720779220779 |
| Not Specified | 24 | 2.625 |
Would you like to find reviews for BUSPAR taken for a specific reason or resulting in a specific side effect?
Filter Results for BUSPAR
FDA Drug Safety Information for BUSPAR
Check here for Ask a Patient's Adverse Event Summary for BUSPAR based on cases submitted to the FDA. Includes top reasons for taking, adverse events, and major outcomes reported.
BUSPAR (BUSPIRONE HYDROCHLORIDE): Buspirone hydrochloride tablets, USP are an antianxiety agent that is not chemically or pharmacologically related to the benzodiazepines, barbiturates, or other sedative/anxiolytic drugs.indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. FDA Approval Date: 1996-04-22 (Sources: U.S. Centers for Medicare Services, FDA)
